About MedTech Barcelona
A leading biotech company focused on developing innovative solutions for the healthcare and pharmaceutical sectors
Who we are
MedTech Innovation on Advanced Medicine (MedTech Barcelona) is a biotechnology company owned by聽Leitat, specializing in the development and commercialization of innovative solutions for the pharmaceutical industry and biomedical research. Our main branch, ReadyCell, is internationally recognized for providing ready-to-use in vitro tools for drug discovery and preclinical development.
With a commitment to innovation and quality, we deliver advanced technologies that enhance research, streamline development, and improve patient outcomes. Our global distribution network spans key markets, including the United States, Europe, India, and Japan.
We support sustainable and ethical practices, guided by the principles of 3R (Reduce, Replace, Refine) and 5S (Seiri, Seiton, Seis艒, Seiketsu, Shitsuke) methodologies.
We work with:
- Clinical Research Organizations (CROs)
- Pharmaceutical Companies
- Biotechnological Companies
- Academic & Research Institutions
- Food & Nutrition Firms
- AI-Driven Biotech Companies
Our Global Reach
Our values and commitment
As part of the聽Leitat, MedTech Barcelona benefits from over 100 years of expertise in research and technological development. This partnership grants us access to advanced laboratories and a network of biotechnology experts. On the other hand, MedTech Barcelona aims to be a commercialization platform for the organization鈥檚 new product developments.
By operating within Leitat’s certified infrastructure, in compliance with the ISO9001 international quality standard, we guarantee that our products meet the highest regulatory and industry requirements in terms of quality and reliability.
Meet the team
Industry Collaborations
We proudly collaborate with leading organizations, distributors and research institutions to drive innovation and progress in biomedical research.
